Lutathera Injection
Product Images NDC 69488-003

3 FDA label images from Advanced Accelerator Applications Usa, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lutathera (NDC 69488-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Accelerator Applications Usa, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lutetium lu 177 Dotatate Structural Formula (Structure)

Lutetium lu 177 Dotatate Structural Formula (Structure)
Chemical structure diagram of Lutetium Lu 177 dotatate, showing the molecular arrangement and various amino acid residues labeled with their abbreviations and positions.*
FDA Label Image

Figure 1. Kaplan-meier Curves For Progression-free Survival In Netter-1 (Figure1)

Figure 1. Kaplan-meier Curves For Progression-free Survival In Netter-1 (Figure1)
A Kaplan-Meier survival curve graph depicting progression-free survival (%) versus time in months for Lutathera and Octreotide. The graph shows two survival lines: one for Lutathera (blue circles) and one for Octreotide (red crosses), with a risk table below indicating the number of subjects at risk over time for each treatment group.*
FDA Label Image

Principal Display Panel Lutathera® Lutetium Lu 177 Dotatate Injection For Intravenous Infusion Single-dose Vial. Discard After 72 Hours. Rx Only Ndc 69488-003-01 Novartis (Lead Shield)

Principal Display Panel							Lutathera®							Lutetium Lu 177 Dotatate Injection							For Intravenous Infusion							Single-dose Vial. Discard After 72 Hours.							Rx Only							Ndc 69488-003-01							Novartis (Lead Shield)
This text panel for Lutathera Lutetium Lu 177 dotatate injection provides dosage instructions, active ingredient concentration (10 mCi/mL or 370 MBq/mL), storage conditions below 25°C with lead shielding, and disposal guidance. It includes manufacturer details, lot, vial, volume, activity at calibration and infusion times, and an expiration date placeholder. A radioactive material caution symbol is present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.